The germline variants of BRCA2, POLE, WRN, FANCI, PALB2, and RAD54B genes, involved in DNS repair mechanisms, have been implicated in rendering melanoma patients more susceptible to tumor progression and affecting their response to treatments [8]. This evidence concerns the gene FANCI and neoplasm.